Live Attenuated Vaccine Market Report

China Live Attenuated Vaccine Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 24, 2022
  • PAGES：221
  • REPORT CODE：GMM1133122
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Live Attenuated Vaccine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Live Attenuated Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Live Attenuated Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Serum Institute of India Pvt (India)

    • CSL Limited (Australia)

    • Pfizer (US)

    • MedImmune (US)

    • Johnson & Johnson (US)

    • Emergent BioSolutions (US)

    • Merck & Co (US)

    • Astellas Pharma (Japan)

    • Sanofi Pasteur (France)

    • GlaxoSmithKline (UK)

    By Type:

    • Pediatrics

    • Adults

    By End-User:

    • Hospital

    • Medical Center

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Live Attenuated Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Live Attenuated Vaccine Market Size and Growth Rate of Pediatrics from 2016 to 2027

    • 1.3.2 China Live Attenuated Vaccine Market Size and Growth Rate of Adults from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Live Attenuated Vaccine Market Size and Growth Rate of Hospital from 2016 to 2027

    • 1.4.2 China Live Attenuated Vaccine Market Size and Growth Rate of Medical Center from 2016 to 2027

    • 1.4.3 China Live Attenuated Vaccine Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Live Attenuated Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Live Attenuated Vaccine by Major Types

    • 3.4.1 Market Size and Growth Rate of Pediatrics

    • 3.4.2 Market Size and Growth Rate of Adults

    4 Segmentation of Live Attenuated Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Live Attenuated Vaccine by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Live Attenuated Vaccine in Hospital

    • 4.4.2 Market Size and Growth Rate of Live Attenuated Vaccine in Medical Center

    • 4.4.3 Market Size and Growth Rate of Live Attenuated Vaccine in Others

    5 Market Analysis by Regions

    • 5.1 China Live Attenuated Vaccine Production Analysis by Regions

    • 5.2 China Live Attenuated Vaccine Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Live Attenuated Vaccine Landscape Analysis

    • 6.1 North China Live Attenuated Vaccine Landscape Analysis by Major Types

    • 6.2 North China Live Attenuated Vaccine Landscape Analysis by Major End-Users

    7 Central China Live Attenuated Vaccine Landscape Analysis

    • 7.1 Central China Live Attenuated Vaccine Landscape Analysis by Major Types

    • 7.2 Central China Live Attenuated Vaccine Landscape Analysis by Major End-Users

    8 South China Live Attenuated Vaccine Landscape Analysis

    • 8.1 South China Live Attenuated Vaccine Landscape Analysis by Major Types

    • 8.2 South China Live Attenuated Vaccine Landscape Analysis by Major End-Users

    9 East China Live Attenuated Vaccine Landscape Analysis

    • 9.1 East China Live Attenuated Vaccine Landscape Analysis by Major Types

    • 9.2 East China Live Attenuated Vaccine Landscape Analysis by Major End-Users

    10 Northeast China Live Attenuated Vaccine Landscape Analysis

    • 10.1 Northeast China Live Attenuated Vaccine Landscape Analysis by Major Types

    • 10.2 Northeast China Live Attenuated Vaccine Landscape Analysis by Major End-Users

    11 Southwest China Live Attenuated Vaccine Landscape Analysis

    • 11.1 Southwest China Live Attenuated Vaccine Landscape Analysis by Major Types

    • 11.2 Southwest China Live Attenuated Vaccine Landscape Analysis by Major End-Users

    12 Northwest China Live Attenuated Vaccine Landscape Analysis

    • 12.1 Northwest China Live Attenuated Vaccine Landscape Analysis by Major Types

    • 12.2 Northwest China Live Attenuated Vaccine Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Serum Institute of India Pvt (India)

      • 13.1.1 Serum Institute of India Pvt (India) Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 CSL Limited (Australia)

      • 13.2.1 CSL Limited (Australia) Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Pfizer (US)

      • 13.3.1 Pfizer (US) Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 MedImmune (US)

      • 13.4.1 MedImmune (US) Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Johnson & Johnson (US)

      • 13.5.1 Johnson & Johnson (US) Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Emergent BioSolutions (US)

      • 13.6.1 Emergent BioSolutions (US) Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Merck & Co (US)

      • 13.7.1 Merck & Co (US) Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Astellas Pharma (Japan)

      • 13.8.1 Astellas Pharma (Japan) Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Sanofi Pasteur (France)

      • 13.9.1 Sanofi Pasteur (France) Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 GlaxoSmithKline (UK)

      • 13.10.1 GlaxoSmithKline (UK) Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Live Attenuated Vaccine Market Size and Growth Rate of Pediatrics from 2016 to 2027

    • Figure China Live Attenuated Vaccine Market Size and Growth Rate of Adults from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Live Attenuated Vaccine Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure China Live Attenuated Vaccine Market Size and Growth Rate of Medical Center from 2016 to 2027

    • Figure China Live Attenuated Vaccine Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Live Attenuated Vaccine Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Live Attenuated Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Live Attenuated Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Live Attenuated Vaccine by Different Types from 2016 to 2027

    • Table Consumption Share of Live Attenuated Vaccine by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Pediatrics

    • Figure Market Size and Growth Rate of Adults

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Live Attenuated Vaccine by Different End-Users from 2016 to 2027

    • Table Consumption Share of Live Attenuated Vaccine by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Medical Center

    • Figure Market Size and Growth Rate of Others

    • Table China Live Attenuated Vaccine Production by Regions

    • Table China Live Attenuated Vaccine Production Share by Regions

    • Figure China Live Attenuated Vaccine Production Share by Regions in 2016

    • Figure China Live Attenuated Vaccine Production Share by Regions in 2021

    • Figure China Live Attenuated Vaccine Production Share by Regions in 2027

    • Table China Live Attenuated Vaccine Consumption by Regions

    • Table China Live Attenuated Vaccine Consumption Share by Regions

    • Figure China Live Attenuated Vaccine Consumption Share by Regions in 2016

    • Figure China Live Attenuated Vaccine Consumption Share by Regions in 2021

    • Figure China Live Attenuated Vaccine Consumption Share by Regions in 2027

    • Table North China Live Attenuated Vaccine Consumption by Types from 2016 to 2027

    • Table North China Live Attenuated Vaccine Consumption Share by Types from 2016 to 2027

    • Figure North China Live Attenuated Vaccine Consumption Share by Types in 2016

    • Figure North China Live Attenuated Vaccine Consumption Share by Types in 2021

    • Figure North China Live Attenuated Vaccine Consumption Share by Types in 2027

    • Table North China Live Attenuated Vaccine Consumption by End-Users from 2016 to 2027

    • Table North China Live Attenuated Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure North China Live Attenuated Vaccine Consumption Share by End-Users in 2016

    • Figure North China Live Attenuated Vaccine Consumption Share by End-Users in 2021

    • Figure North China Live Attenuated Vaccine Consumption Share by End-Users in 2027

    • Table Central China Live Attenuated Vaccine Consumption by Types from 2016 to 2027

    • Table Central China Live Attenuated Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Central China Live Attenuated Vaccine Consumption Share by Types in 2016

    • Figure Central China Live Attenuated Vaccine Consumption Share by Types in 2021

    • Figure Central China Live Attenuated Vaccine Consumption Share by Types in 2027

    • Table Central China Live Attenuated Vaccine Consumption by End-Users from 2016 to 2027

    • Table Central China Live Attenuated Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Live Attenuated Vaccine Consumption Share by End-Users in 2016

    • Figure Central China Live Attenuated Vaccine Consumption Share by End-Users in 2021

    • Figure Central China Live Attenuated Vaccine Consumption Share by End-Users in 2027

    • Table South China Live Attenuated Vaccine Consumption by Types from 2016 to 2027

    • Table South China Live Attenuated Vaccine Consumption Share by Types from 2016 to 2027

    • Figure South China Live Attenuated Vaccine Consumption Share by Types in 2016

    • Figure South China Live Attenuated Vaccine Consumption Share by Types in 2021

    • Figure South China Live Attenuated Vaccine Consumption Share by Types in 2027

    • Table South China Live Attenuated Vaccine Consumption by End-Users from 2016 to 2027

    • Table South China Live Attenuated Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure South China Live Attenuated Vaccine Consumption Share by End-Users in 2016

    • Figure South China Live Attenuated Vaccine Consumption Share by End-Users in 2021

    • Figure South China Live Attenuated Vaccine Consumption Share by End-Users in 2027

    • Table East China Live Attenuated Vaccine Consumption by Types from 2016 to 2027

    • Table East China Live Attenuated Vaccine Consumption Share by Types from 2016 to 2027

    • Figure East China Live Attenuated Vaccine Consumption Share by Types in 2016

    • Figure East China Live Attenuated Vaccine Consumption Share by Types in 2021

    • Figure East China Live Attenuated Vaccine Consumption Share by Types in 2027

    • Table East China Live Attenuated Vaccine Consumption by End-Users from 2016 to 2027

    • Table East China Live Attenuated Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure East China Live Attenuated Vaccine Consumption Share by End-Users in 2016

    • Figure East China Live Attenuated Vaccine Consumption Share by End-Users in 2021

    • Figure East China Live Attenuated Vaccine Consumption Share by End-Users in 2027

    • Table Northeast China Live Attenuated Vaccine Consumption by Types from 2016 to 2027

    • Table Northeast China Live Attenuated Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Live Attenuated Vaccine Consumption Share by Types in 2016

    • Figure Northeast China Live Attenuated Vaccine Consumption Share by Types in 2021

    • Figure Northeast China Live Attenuated Vaccine Consumption Share by Types in 2027

    • Table Northeast China Live Attenuated Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northeast China Live Attenuated Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Live Attenuated Vaccine Consumption Share by End-Users in 2016

    • Figure Northeast China Live Attenuated Vaccine Consumption Share by End-Users in 2021

    • Figure Northeast China Live Attenuated Vaccine Consumption Share by End-Users in 2027

    • Table Southwest China Live Attenuated Vaccine Consumption by Types from 2016 to 2027

    • Table Southwest China Live Attenuated Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Live Attenuated Vaccine Consumption Share by Types in 2016

    • Figure Southwest China Live Attenuated Vaccine Consumption Share by Types in 2021

    • Figure Southwest China Live Attenuated Vaccine Consumption Share by Types in 2027

    • Table Southwest China Live Attenuated Vaccine Consumption by End-Users from 2016 to 2027

    • Table Southwest China Live Attenuated Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Live Attenuated Vaccine Consumption Share by End-Users in 2016

    • Figure Southwest China Live Attenuated Vaccine Consumption Share by End-Users in 2021

    • Figure Southwest China Live Attenuated Vaccine Consumption Share by End-Users in 2027

    • Table Northwest China Live Attenuated Vaccine Consumption by Types from 2016 to 2027

    • Table Northwest China Live Attenuated Vaccine Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Live Attenuated Vaccine Consumption Share by Types in 2016

    • Figure Northwest China Live Attenuated Vaccine Consumption Share by Types in 2021

    • Figure Northwest China Live Attenuated Vaccine Consumption Share by Types in 2027

    • Table Northwest China Live Attenuated Vaccine Consumption by End-Users from 2016 to 2027

    • Table Northwest China Live Attenuated Vaccine Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Live Attenuated Vaccine Consumption Share by End-Users in 2016

    • Figure Northwest China Live Attenuated Vaccine Consumption Share by End-Users in 2021

    • Figure Northwest China Live Attenuated Vaccine Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Serum Institute of India Pvt (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Serum Institute of India Pvt (India)

    • Figure Sales and Growth Rate Analysis of Serum Institute of India Pvt (India)

    • Figure Revenue and Market Share Analysis of Serum Institute of India Pvt (India)

    • Table Product and Service Introduction of Serum Institute of India Pvt (India)

    • Table Company Profile and Development Status of CSL Limited (Australia)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Limited (Australia)

    • Figure Sales and Growth Rate Analysis of CSL Limited (Australia)

    • Figure Revenue and Market Share Analysis of CSL Limited (Australia)

    • Table Product and Service Introduction of CSL Limited (Australia)

    • Table Company Profile and Development Status of Pfizer (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer (US)

    • Figure Sales and Growth Rate Analysis of Pfizer (US)

    • Figure Revenue and Market Share Analysis of Pfizer (US)

    • Table Product and Service Introduction of Pfizer (US)

    • Table Company Profile and Development Status of MedImmune (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedImmune (US)

    • Figure Sales and Growth Rate Analysis of MedImmune (US)

    • Figure Revenue and Market Share Analysis of MedImmune (US)

    • Table Product and Service Introduction of MedImmune (US)

    • Table Company Profile and Development Status of Johnson & Johnson (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson (US)

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson (US)

    • Figure Revenue and Market Share Analysis of Johnson & Johnson (US)

    • Table Product and Service Introduction of Johnson & Johnson (US)

    • Table Company Profile and Development Status of Emergent BioSolutions (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent BioSolutions (US)

    • Figure Sales and Growth Rate Analysis of Emergent BioSolutions (US)

    • Figure Revenue and Market Share Analysis of Emergent BioSolutions (US)

    • Table Product and Service Introduction of Emergent BioSolutions (US)

    • Table Company Profile and Development Status of Merck & Co (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co (US)

    • Figure Sales and Growth Rate Analysis of Merck & Co (US)

    • Figure Revenue and Market Share Analysis of Merck & Co (US)

    • Table Product and Service Introduction of Merck & Co (US)

    • Table Company Profile and Development Status of Astellas Pharma (Japan)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma (Japan)

    • Figure Sales and Growth Rate Analysis of Astellas Pharma (Japan)

    • Figure Revenue and Market Share Analysis of Astellas Pharma (Japan)

    • Table Product and Service Introduction of Astellas Pharma (Japan)

    • Table Company Profile and Development Status of Sanofi Pasteur (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur (France)

    • Figure Sales and Growth Rate Analysis of Sanofi Pasteur (France)

    • Figure Revenue and Market Share Analysis of Sanofi Pasteur (France)

    • Table Product and Service Introduction of Sanofi Pasteur (France)

    • Table Company Profile and Development Status of GlaxoSmithKline (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline (UK)

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline (UK)

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline (UK)

    • Table Product and Service Introduction of GlaxoSmithKline (UK)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US